1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Nuclear Medicines Consumption 2015-2025

2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region

2.2 Therapeutic Nuclear Medicines Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Therapeutic Nuclear Medicines Consumption by Type

2.3.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2015-2020)

2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2015-2020)

2.4 Therapeutic Nuclear Medicines Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Therapeutic Nuclear Medicines Consumption by Application

2.5.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

2.5.2 Global Therapeutic Nuclear Medicines Value and Market Share by Type (2015-2020)

2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2015-2020)

3 Global Therapeutic Nuclear Medicines by Company

3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Company

3.1.1 Global Therapeutic Nuclear Medicines Sales by Company (2018-2020)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2018-2020)

3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2018-2020)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2018-2020)

3.3 Global Therapeutic Nuclear Medicines Sale Price by Company

3.4 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Therapeutic Nuclear Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Medicines by Regions

4.1 Therapeutic Nuclear Medicines by Regions

4.2 Americas Therapeutic Nuclear Medicines Consumption Growth

4.3 APAC Therapeutic Nuclear Medicines Consumption Growth

4.4 Europe Therapeutic Nuclear Medicines Consumption Growth

4.5 Middle East & Africa Therapeutic Nuclear Medicines Consumption Growth

5 Americas

5.1 Americas Therapeutic Nuclear Medicines Consumption by Countries

5.1.1 Americas Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

5.1.2 Americas Therapeutic Nuclear Medicines Value by Countries (2015-2020)

5.2 Americas Therapeutic Nuclear Medicines Consumption by Type

5.3 Americas Therapeutic Nuclear Medicines Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Therapeutic Nuclear Medicines Consumption by Regions

6.1.1 APAC Therapeutic Nuclear Medicines Consumption by Regions (2015-2020)

6.1.2 APAC Therapeutic Nuclear Medicines Value by Regions (2015-2020)

6.2 APAC Therapeutic Nuclear Medicines Consumption by Type

6.3 APAC Therapeutic Nuclear Medicines Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Therapeutic Nuclear Medicines by Countries

7.1.1 Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

7.1.2 Europe Therapeutic Nuclear Medicines Value by Countries (2015-2020)

7.2 Europe Therapeutic Nuclear Medicines Consumption by Type

7.3 Europe Therapeutic Nuclear Medicines Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Nuclear Medicines by Countries

8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2015-2020)

8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type

8.3 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Therapeutic Nuclear Medicines Distributors

10.3 Therapeutic Nuclear Medicines Customer

11 Global Therapeutic Nuclear Medicines Market Forecast

11.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2021-2025)

11.2 Global Therapeutic Nuclear Medicines Forecast by Regions

11.2.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2021-2025)

11.2.2 Global Therapeutic Nuclear Medicines Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Therapeutic Nuclear Medicines Forecast by Type

11.8 Global Therapeutic Nuclear Medicines Forecast by Application

12 Key Players Analysis

12.1 Novartis AG

12.1.1 Company Information

12.1.2 Therapeutic Nuclear Medicines Product Offered

12.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Novartis AG Latest Developments

12.2 Progenics Pharmaceuticals

12.2.1 Company Information

12.2.2 Therapeutic Nuclear Medicines Product Offered

12.2.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Progenics Pharmaceuticals Latest Developments

12.3 Bayer

12.3.1 Company Information

12.3.2 Therapeutic Nuclear Medicines Product Offered

12.3.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Bayer Latest Developments

12.4 Q BioMed

12.4.1 Company Information

12.4.2 Therapeutic Nuclear Medicines Product Offered

12.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Q BioMed Latest Developments

12.5 Curium Pharmaceuticals

12.5.1 Company Information

12.5.2 Therapeutic Nuclear Medicines Product Offered

12.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Curium Pharmaceuticals Latest Developments

12.6 China Isotope & Radiation

12.6.1 Company Information

12.6.2 Therapeutic Nuclear Medicines Product Offered

12.6.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 China Isotope & Radiation Latest Developments

12.7 Lantheus

12.7.1 Company Information

12.7.2 Therapeutic Nuclear Medicines Product Offered

12.7.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Lantheus Latest Developments

12.8 Jubilant DraxImage

12.8.1 Company Information

12.8.2 Therapeutic Nuclear Medicines Product Offered

12.8.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Jubilant DraxImage Latest Developments

12.9 Acrotech Biopharma.

12.9.1 Company Information

12.9.2 Therapeutic Nuclear Medicines Product Offered

12.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Acrotech Biopharma. Latest Developments

12.10 Dongcheng

12.10.1 Company Information

12.10.2 Therapeutic Nuclear Medicines Product Offered

12.10.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Dongcheng Latest Developments

12.11 International Isotopes

12.11.1 Company Information

12.11.2 Therapeutic Nuclear Medicines Product Offered

12.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 International Isotopes Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Therapeutic Nuclear Medicines Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Radium-223

Table 5. Major Players of Lutetium-177

Table 6. Major Players of Iodine-131

Table 7. Major Players of Other

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Table 10. Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020) ($ million)

Table 11. Global Therapeutic Nuclear Medicines Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Therapeutic Nuclear Medicines Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 15. Global Therapeutic Nuclear Medicines Value by Application (2015-2020)

Table 16. Global Therapeutic Nuclear Medicines Value Market Share by Application (2015-2020)

Table 17. Global Therapeutic Nuclear Medicines Sale Price by Application (2015-2020)

Table 18. Global Therapeutic Nuclear Medicines Sales by Company (2017-2019) (K Units)

Table 19. Global Therapeutic Nuclear Medicines Sales Market Share by Company (2017-2019)

Table 20. Global Therapeutic Nuclear Medicines Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2017-2019)

Table 22. Global Therapeutic Nuclear Medicines Sale Price by Company (2017-2019)

Table 23. Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Therapeutic Nuclear Medicines Products Offered

Table 25. Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Therapeutic Nuclear Medicines Consumption by Regions 2015-2020 (K Units)

Table 27. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2015-2020

Table 28. Global Therapeutic Nuclear Medicines Value by Regions 2015-2020 ($ Millions)

Table 29. Global Therapeutic Nuclear Medicines Value Market Share by Regions 2015-2020

Table 30. Americas Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 31. Americas Therapeutic Nuclear Medicines Consumption Market Share by Countries (2015-2020)

Table 32. Americas Therapeutic Nuclear Medicines Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Therapeutic Nuclear Medicines Value Market Share by Countries (2015-2020)

Table 34. Americas Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units)

Table 35. Americas Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Table 36. Americas Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)

Table 37. Americas Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 38. APAC Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 39. APAC Therapeutic Nuclear Medicines Consumption Market Share by Countries (2015-2020)

Table 40. APAC Therapeutic Nuclear Medicines Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Therapeutic Nuclear Medicines Value Market Share by Regions (2015-2020)

Table 42. APAC Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units)

Table 43. APAC Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Table 44. APAC Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)

Table 45. APAC Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 46. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 47. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries (2015-2020)

Table 48. Europe Therapeutic Nuclear Medicines Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Therapeutic Nuclear Medicines Value Market Share by Countries (2015-2020)

Table 50. Europe Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units)

Table 51. Europe Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Table 52. Europe Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)

Table 53. Europe Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 55. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Therapeutic Nuclear Medicines Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units)

Table 59. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)

Table 61. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 62. Therapeutic Nuclear Medicines Distributors List

Table 63. Therapeutic Nuclear Medicines Customer List

Table 64. Global Therapeutic Nuclear Medicines Consumption Forecast by Countries (2021-2025) (K Units)

Table 65. Global Therapeutic Nuclear Medicines Consumption Market Forecast by Regions

Table 66. Global Therapeutic Nuclear Medicines Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Therapeutic Nuclear Medicines Value Market Share Forecast by Regions

Table 68. Global Therapeutic Nuclear Medicines Consumption Forecast by Type (2021-2025) (K Units)

Table 69. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Therapeutic Nuclear Medicines Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Therapeutic Nuclear Medicines Value Market Share Forecast by Type (2021-2025)

Table 72. Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2021-2025) (K Units)

Table 73. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Therapeutic Nuclear Medicines Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Therapeutic Nuclear Medicines Value Market Share Forecast by Application (2021-2025)

Table 76. Novartis AG Product Offered

Table 77. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 78. Novartis AG Main Business

Table 79. Novartis AG Latest Developments

Table 80. Novartis AG Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 81. Progenics Pharmaceuticals Product Offered

Table 82. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 83. Progenics Pharmaceuticals Main Business

Table 84. Progenics Pharmaceuticals Latest Developments

Table 85. Progenics Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 86. Bayer Product Offered

Table 87. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 88. Bayer Main Business

Table 89. Bayer Latest Developments

Table 90. Bayer Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 91. Q BioMed Product Offered

Table 92. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 93. Q BioMed Main Business

Table 94. Q BioMed Latest Developments

Table 95. Q BioMed Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 96. Curium Pharmaceuticals Product Offered

Table 97. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 98. Curium Pharmaceuticals Main Business

Table 99. Curium Pharmaceuticals Latest Developments

Table 100. Curium Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 101. China Isotope & Radiation Product Offered

Table 102. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 103. China Isotope & Radiation Main Business

Table 104. China Isotope & Radiation Latest Developments

Table 105. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 106. Lantheus Product Offered

Table 107. Lantheus Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 108. Lantheus Main Business

Table 109. Lantheus Latest Developments

Table 110. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 111. Jubilant DraxImage Product Offered

Table 112. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 113. Jubilant DraxImage Main Business

Table 114. Jubilant DraxImage Latest Developments

Table 115. Jubilant DraxImage Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 116. Acrotech Biopharma. Product Offered

Table 117. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 118. Acrotech Biopharma. Main Business

Table 119. Acrotech Biopharma. Latest Developments

Table 120. Acrotech Biopharma. Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 121. Dongcheng Product Offered

Table 122. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 123. Dongcheng Main Business

Table 124. Dongcheng Latest Developments

Table 125. Dongcheng Basic Information, Company Total Revenue (in $ million), Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 126. International Isotopes Product Offered

Table 127. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 128. International Isotopes Main Business

Table 129. International Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 130. International Isotopes Latest Developments

List of Figures

Figure 1. Picture of Therapeutic Nuclear Medicines

Figure 2. Therapeutic Nuclear Medicines Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Therapeutic Nuclear Medicines Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Therapeutic Nuclear Medicines Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Radium-223

Figure 7. Product Picture of Lutetium-177

Figure 8. Product Picture of Iodine-131

Figure 9. Product Picture of Other

Figure 10. Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

Figure 11. Global Therapeutic Nuclear Medicines Value Market Share by Type (2015-2020)

Figure 12. Therapeutic Nuclear Medicines Consumed in Thyroid

Figure 13. Global Therapeutic Nuclear Medicines Market: Thyroid (2015-2020) (K Units)

Figure 14. Global Therapeutic Nuclear Medicines Market: Thyroid (2015-2020) ($ Millions)

Figure 15. Therapeutic Nuclear Medicines Consumed in Bone Metastasis

Figure 16. Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2015-2020) (K Units)

Figure 17. Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2015-2020) ($ Millions)

Figure 18. Therapeutic Nuclear Medicines Consumed in Lymphoma

Figure 19. Global Therapeutic Nuclear Medicines Market: Lymphoma (2015-2020) (K Units)

Figure 20. Global Therapeutic Nuclear Medicines Market: Lymphoma (2015-2020) ($ Millions)

Figure 21. Therapeutic Nuclear Medicines Consumed in Other

Figure 22. Global Therapeutic Nuclear Medicines Market: Other (2015-2020) (K Units)

Figure 23. Global Therapeutic Nuclear Medicines Market: Other (2015-2020) ($ Millions)

Figure 24. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Figure 25. Global Therapeutic Nuclear Medicines Value Market Share by Application (2015-2020)

Figure 26. Global Therapeutic Nuclear Medicines Sales Market Share by Company in 2017

Figure 27. Global Therapeutic Nuclear Medicines Sales Market Share by Company in 2019

Figure 28. Global Therapeutic Nuclear Medicines Revenue Market Share by Company in 2017

Figure 29. Global Therapeutic Nuclear Medicines Revenue Market Share by Company in 2019

Figure 30. Global Therapeutic Nuclear Medicines Sale Price by Company in 2019

Figure 31. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2015-2020

Figure 32. Global Therapeutic Nuclear Medicines Value Market Share by Regions 2015-2020

Figure 33. Americas Therapeutic Nuclear Medicines Consumption 2015-2020 (K Units)

Figure 34. Americas Therapeutic Nuclear Medicines Value 2015-2020 ($ Millions)

Figure 35. APAC Therapeutic Nuclear Medicines Consumption 2015-2020 (K Units)

Figure 36. APAC Therapeutic Nuclear Medicines Value 2015-2020 ($ Millions)

Figure 37. Europe Therapeutic Nuclear Medicines Consumption 2015-2020 (K Units)

Figure 38. Europe Therapeutic Nuclear Medicines Value 2015-2020 ($ Millions)

Figure 39. Middle East & Africa Therapeutic Nuclear Medicines Consumption 2015-2020 (K Units)

Figure 40. Middle East & Africa Therapeutic Nuclear Medicines Value 2015-2020 ($ Millions)

Figure 41. Americas Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 42. Americas Therapeutic Nuclear Medicines Value Market Share by Countries in 2019

Figure 43. Americas Therapeutic Nuclear Medicines Consumption Market Share by Type in 2019

Figure 44. Americas Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019

Figure 45. United States Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 46. United States Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 47. Canada Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 48. Canada Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 49. Mexico Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 50. Mexico Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 51. APAC Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 52. APAC Therapeutic Nuclear Medicines Value Market Share by Regions in 2019

Figure 53. APAC Therapeutic Nuclear Medicines Consumption Market Share by Type in 2019

Figure 54. APAC Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019

Figure 55. China Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 56. China Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 57. Japan Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 58. Japan Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 59. Korea Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 60. Korea Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 61. Southeast Asia Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 62. Southeast Asia Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 63. India Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 64. India Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 65. Australia Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 66. Australia Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 67. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 68. Europe Therapeutic Nuclear Medicines Value Market Share by Countries in 2019

Figure 69. Europe Therapeutic Nuclear Medicines Consumption Market Share by Type in 2019

Figure 70. Europe Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019

Figure 71. Germany Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 72. Germany Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 73. France Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 74. France Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 75. UK Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 76. UK Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 77. Italy Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 78. Italy Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 79. Russia Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 80. Russia Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 81. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 82. Middle East & Africa Therapeutic Nuclear Medicines Value Market Share by Countries in 2019

Figure 83. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Type in 2019

Figure 84. Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019

Figure 85. Egypt Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 86. Egypt Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 87. South Africa Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 88. South Africa Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 89. Israel Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 90. Israel Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 91. Turkey Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 92. Turkey Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 93. GCC Countries Therapeutic Nuclear Medicines Consumption Growth 2015-2020 (K Units)

Figure 94. GCC Countries Therapeutic Nuclear Medicines Value Growth 2015-2020 ($ Millions)

Figure 95. Global Therapeutic Nuclear Medicines Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 96. Global Therapeutic Nuclear Medicines Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 97. Americas Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 98. Americas Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 99. APAC Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 100. APAC Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 101. Europe Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 102. Europe Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 103. Middle East & Africa Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 104. Middle East & Africa Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 105. United States Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 106. United States Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 107. Canada Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 108. Canada Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 109. Mexico Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 110. Mexico Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 111. Brazil Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 112. Brazil Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 113. China Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 114. China Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 115. Japan Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 116. Japan Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 117. Korea Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 118. Korea Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 119. Southeast Asia Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 120. Southeast Asia Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 121. India Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 122. India Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 123. Australia Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 124. Australia Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 125. Germany Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 126. Germany Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 127. France Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 128. France Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 129. UK Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 130. UK Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 131. Italy Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 132. Italy Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 133. Russia Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 134. Russia Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 135. Spain Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 136. Spain Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 137. Egypt Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 138. Egypt Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 139. South Africa Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 140. South Africa Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 141. Israel Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 142. Israel Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 143. Turkey Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 144. Turkey Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 145. GCC Countries Therapeutic Nuclear Medicines Consumption 2021-2025 (K Units)

Figure 146. GCC Countries Therapeutic Nuclear Medicines Value 2021-2025 ($ Millions)

Figure 147. Novartis AG Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 148. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 149. Bayer Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 150. Q BioMed Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 151. Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 152. China Isotope & Radiation Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 153. Lantheus Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 154. Jubilant DraxImage Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 155. Acrotech Biopharma. Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 156. Dongcheng Therapeutic Nuclear Medicines Market Share (2018-2020)

Figure 157. International Isotopes Therapeutic Nuclear Medicines Market Share (2018-2020)